The Star on MSN
When lupus turned against her body
For Teresa Kariuki, 32, illness began quietly. As a child growing up in Aguthi ward, Gichira sublocation, Nyeri county, she was an ordinary schoolgirl, obedient and determined to complete her ...
Novartis (NVS) has terminated a mid-stage trial for its oral Factor B inhibitor Fabhalta (iptacopan) in lupus nephritis, an inflammatory condition affecting the kidneys, because of strategic ...
The nuclear verdict against C.H. Robinson in Texas has been affirmed. The post BREAKING: Texas judge upholds nuclear verdict against C.H. Robinson appeared first on FreightWaves.
COMMENTARY: O’Connor’s enjoyment of the natural world, despite the terribly debilitating dis-ease she suffered ...
Novartis has ended a mid-stage trial of Fabhalta for lupus nephritis, citing strategic considerations. The clinical-trial registry offered no further explanation and did not indicate whether safety or ...
JPMorgan analyst Chris Schott raises Biogen (BIIB) price target to $300 from $210, citing felzartamab and litifilimab catalysts for 2027.
The 35th Annual Lupus Loop and Walk to End Lupus Now is part of the Lupus Foundation of America’s signature walk program. Hosted by the Pennsylvania Delaware Valley Region of the Lupus Foundation of ...
The development comes as TSMC is pouring $265 billion into setting up chip-making operations in the U.S. amid a push from U.S ...
O Gazyva (obinutuzumabe) recebeu da Anvisa uma nova indicação de uso: o tratamento de adultos que enfrentam lúpus eritematoso ...
Droga já era empregada no tratamento de alguns tipos de câncer, e agora tem nova indicação nova, mas custo elevado ainda pode frear acesso à terapia ...
La Plataforma de Organizaciones de Pacientes (POP) celebró este viernes en Madrid su Asamblea General Extraordinaria, en la ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results